LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED JUTHA MARITIME PUBLIC COMPANY LIMITED JWD INFOLOGISTICS PUBLIC COMPANY LIMITED K&K
LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED JUTHA MARITIME PUBLIC COMPANY LIMITED JWD INFOLOGISTICS PUBLIC COMPANY LIMITED K&K
LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED JUTHA MARITIME PUBLIC COMPANY LIMITED JWD INFOLOGISTICS PUBLIC COMPANY LIMITED K&K
LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED JUTHA MARITIME PUBLIC COMPANY LIMITED JWD INFOLOGISTICS PUBLIC COMPANY LIMITED K&K
LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED JUTHA MARITIME PUBLIC COMPANY LIMITED JWD INFOLOGISTICS PUBLIC COMPANY LIMITED K&K
LIMITED JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JUBILEE ENTERPRISE PUBLIC COMPANY LIMITED JUTHA MARITIME PUBLIC COMPANY LIMITED JWD INFOLOGISTICS PUBLIC COMPANY LIMITED K&K
35,000,000, equivalent to 6.40 percent of the registered and paid-up capital after subscription of newly issued ordinary shares. All of them are corporate and individual investors with a stable financial
capital after subscription of newly issued ordinary shares. All of them are corporate and individual investors with a stable financial position who are able to invest in the Company to support and increase
E_1 Legal_FA_2015_12_29-c A HibrWCorpL.1hig A Executive Summary Management Discussion and Analysis For the Quarter Ending September 30, 2018 The Thai economy in the third quarter of 2018 grew at a decelerating rate due to slowdown in external sector and manufacturing production at home. Meanwhile, private consumption which continued to expand was derived mainly from increased expenditures on automobiles. Nonetheless, the business sector remained challenged by new modes of competition, the broade...
which will be due in 2021-2024. 6. Benefits which the Company will receive from the capital increase/share allotment The capital increase will result in a stronger and more stable financial structure, in